Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Teligent, Inc.
Report date August 19, 2020 · Filed September 16, 2020
Jointly reported with LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP, LIFE SCIENCES OPPORTUNITIES FUND II LP, SIGNET HEALTHCARE PARTNERS, LLC, SANDERS DON A, MORRIS BEN T, WEIR DONALD V
Section 16 reporting ended · disclosed 2020-09-16. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 761,680 |
Reported balance
After 2020-08-19 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-08-19 · Sale · Disposed 74,020 · Balance 761,680 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 136,237 |
Reported balance
After 2020-08-19 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2020-08-19 · Sale · Disposed 13,251 · Balance 136,237 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 658,718 |
Reported balance
After 2020-08-21 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2020-08-21 · Sale · Disposed 102,962 · Balance 658,718 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 117,805 |
Reported balance
After 2020-08-21 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2020-08-21 · Sale · Disposed 18,432 · Balance 117,805 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 573,902 |
Reported balance
After 2020-08-25 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2020-08-25 · Sale · Disposed 84,816 · Balance 573,902 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 102,621 |
Reported balance
After 2020-08-25 transaction · row 6
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 6 · 2020-08-25 · Sale · Disposed 15,184 · Balance 102,621 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 98,390 |
Reported balance
After 2020-08-26 transaction · row 7
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 7 · 2020-08-26 · Sale · Disposed 475,512 · Balance 98,390 F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
| Common StockSEC Table I · non-derivative | Direct | 17,515 |
Reported balance
After 2020-08-26 transaction · row 8
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 8 · 2020-08-26 · Sale · Disposed 85,106 · Balance 17,515 F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. |
Filing footnotes · ownership attribution and instrument terms
F1: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
F2: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 26, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 85,106 | $1.25 | $106,195.27 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 8 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,515 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 26, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 475,512 | $1.24 | $591,299.17 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 7 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,390 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 25, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 15,184 | $1.13 | $17,106.29 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 6 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,621 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 25, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 84,816 | $1.13 | $96,147.42 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 5 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 573,902 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 21, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 18,432 | $1.66 | $30,539.98 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 4 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,805 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 21, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 102,962 | $1.66 | $171,071.36 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 3 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658,718 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 19, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 13,251 | $2.25 | $29,760.42 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 2 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,237 F2 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund II, L.P. and indirectly by the General Partner, Mr. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW, and Mr. Sanders, Mr. Morris, and Mr. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| August 19, 2020 Filed Sep 16, 2020 20:44 UTC | Teligent, Inc. TLGT · Entity 134764 | SaleCommon Stock | 74,020 | $2.26 | $167,026.13 |
DisclosureSEC source: 0001213900-20-027008 · ownership.xml · nonDerivative · entry 1 LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP · CIK 0001269417 · Director · 10% owner LIFE SCIENCES OPPORTUNITIES FUND II LP · CIK 0001269415 · 10% owner SIGNET HEALTHCARE PARTNERS, LLC · CIK 0001280952 · 10% owner GALE JAMES C · CIK 0001184312 · Director · 10% owner SANDERS DON A · CIK 0000904778 · 10% owner MORRIS BEN T · CIK 0001214494 · 10% owner WEIR DONALD V · CIK 0001006309 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 761,680 F1 · ownership.direct: These securities are owned directly by Life Sciences Opportunities Fund (Institutional) II, L.P. and indirectly by the Signet Healthcare Partners, LLC ("General Partner"), the general partner of Life Sciences Opportunities Fund II, L.P., James C. Gale, the chief investment officer, a manager, and a member of the General Partner, SMW Investments I, LLC ("SMW") and Don A. Sanders, Ben T. Morris, and Donald V. Weir, the managing members of SMW. The General Partner, Mr. Gale, SMW, Mr. Sanders, Mr. Morris, and Mr. Weir disclaim beneficial ownership of the reported securities except to the extent of their pecuniary interest therein, if any. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 10:47 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-20-000628 · tm201128d1_4.xml · derivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-01-02 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These securities shall vest fully 12 months from the date of grant. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 17:55 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 10,653 | $0.00 Strike: $0.88 | $0.00 |
DisclosureSEC source: 0001144204-19-047418 · tv530698_form4.xml · derivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,653 Underlying: Common Stock · 10,653 shares Expires 2029-10-02 F1 · security: These securities were issued pursuant to the terms of the Non-employee Directors Compensation Policy as compensation for services provided to the Board for the fourth quarter of 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 11:38 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 14,423 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001144204-19-033718 · tv524756_form4.xml · derivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,423 Underlying: Common Stock · 14,423 shares Expires 2029-07-01 F1 · security: These securities were issued pursuant to the terms of the Non-employee Directors Compensation Policy as compensation for services provided to the Board for the third quarter of 2019. Read SEC document |
| May 31, 2019 Filed May 31, 2019 18:28 UTC | Teligent, Inc. TLGT · Entity 134764 | PurchaseCommon Stock | 20,000 | $0.66 | $13,166.00 |
DisclosureSEC source: 0001144204-19-029304 · tv522861_form4.xml · nonDerivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 394,624 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.6550 to $0.6599, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4. Read SEC document |
| May 23, 2019 Filed May 24, 2019 08:00 UTC | Teligent, Inc. TLGT · Entity 134764 | PurchaseCommon Stock | 20,000 | $0.69 | $13,814.00 |
DisclosureSEC source: 0001144204-19-028059 · tv522415_form4.xml · nonDerivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,624 Read SEC document |
| May 13, 2019 Filed May 15, 2019 18:21 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 10,901 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001144204-19-026689 · tv521749_form4.xml · derivative · entry 2 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,901 Underlying: Common Stock · 10,901 shares Expires 2029-05-13 F2 · security: These securities were issued pursuant to the terms of the Non-employee Director Compensation Policy as compensation for services provided to the Board in the second quarter of 2019. Read SEC document |
| May 13, 2019 Filed May 15, 2019 18:21 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 10,901 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001144204-19-026689 · tv521749_form4.xml · derivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,901 Underlying: Common Stock · 10,901 shares Expires 2029-05-13 F1 · security: These securities were issued pursuant to the terms of the Non-employee Director Compensation Policy as compensation for services provided to the Board in the first quarter of 2019. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:02 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001144204-19-000654 · tv510284_4.xml · derivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-02 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These securities shall vest fully 12 months from the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:05 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001144204-18-000812 · tv482600_form4.xml · derivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-01-02 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These securities shall vest fully 12 months from the date of grant. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 17:01 UTC | Teligent, Inc. TLGT · Entity 134764 | PurchaseCommon Stock | 15,000 | $3.81 | $57,136.50 |
DisclosureSEC source: 0001144204-17-058439 · tv479211_form4.xml · nonDerivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 354,624 Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 16:24 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0001144204-17-000872 · v456322_form4.xml · derivative · entry 1 GALE JAMES C · CIK 0001184312 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-03 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These securities shall vest fully 12 months from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.